Introduction – Company Background
GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.
With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.
With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.
From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.
At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.
By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.
Core Strengths in Insole Manufacturing
At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.
Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.
We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.
With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.
Customization & OEM/ODM Flexibility
GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.
Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.
With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.
Quality Assurance & Certifications
Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.
We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.
Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.
ESG-Oriented Sustainable Production
At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.
To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.
We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.
Let’s Build Your Next Insole Success Together
Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.
From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.
Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.
🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw
PU insole OEM production in China
Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.
With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Taiwan OEM insole and pillow manufacturing factory
Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.
We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.ODM pillow for sleep brands Thailand
At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Arch support insole OEM from Vietnam
📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Eco-friendly pillow OEM factory Taiwan
Microalgae cultivation facility along the Kona Coast of Hawaii’s Big Island. Image provided by the Cyanotech Corporation. Credit: Greene, C.H., C.M. Scott-Buechler, A.L.P. Hausner, Z.I. Johnson, X. Lei, and M.E. Huntley. 2022. Transforming the future of marine aquaculture: A circular economy approach. Oceanography, p. 28, doi.org/10.5670/oceanog.2022.213, CC-BY 4.0 A new article proposes algae aquaculture as an eco-friendly alternative to traditional farming. Rich in nutrients, microalgae could meet food demands sustainably, though it faces economic challenges without government aid. Terrestrial agriculture provides the backbone of the world’s food production system. A new opinion article published in the open-access journal PLOS Biology makes the case for increased investment in algae aquaculture systems as a means of meeting nutritional needs while reducing the ecological footprint of food production. Authored by Charles H. Greene at University of Washington, Friday Harbor, Washington, and Celina M. Scott-Buechler at Stanford University, Palo Alto, California, the article was published on October 17. Detrimental impacts on climate, land use, freshwater resources, and biodiversity would result from increasing agriculture and fisheries production to meet consumer demand. In their article, the authors argue for shifting the focus of marine aquaculture down the food chain to algae. This could potentially supply the growing demand for nutritious food in addition to reducing the current food system’s ecological footprint. Charles Greene. Credit: Charles Greene, CC BY 4.0 Nutritional Potential of Microalgae Microalgae could provide high amounts of nutritional protein and essential amino acids, in addition to other micronutrients, such as vitamins and antioxidants. Moreover, a marine microalgae-based aquaculture industry would not require arable land and freshwater, or pollute freshwater and marine ecosystems through fertilizer runoff. The article does not address the potential for a new algae-based aquaculture industry to be culturally responsive, how large-scale microalgae production would affect local foodways, or how algae tastes. According to the authors, “The financial headwinds faced by a new marine microalgae-based aquaculture industry will be stiff because it must challenge incumbent industries for market share before its technologies are completely mature and it can achieve the full benefits of scale. Financial investments and market incentives provided by state and federal governments can help reduce this green premium until the playing field is level. The future role of algae-based solutions in achieving global food security and environmental sustainability will depend on the actions taken by governments today.” Greene adds, “Agriculture provides the backbone of today’s global food production system; however, its potential to meet the world’s nutritional demands by 2050 is limited. Marine microalgae can help fill the projected nutritional gap while simultaneously improving overall environmental sustainability and ocean health.” Interview with Associate Director for Research and Strategic Planning Dr. Charles H. Greene What first drew you to study microalgae and sustainability? About a dozen years ago, I came to the conclusion that too many Earth scientists were focusing only on the impacts of climate change and not looking for solutions to the problem. A colleague of mine, Dr. Mark Huntley, invited me to join his team investigating the potential of marine microalgae in the production of biofuels. Over time, our thinking evolved, and we realized that marine microalgae have tremendous potential for addressing the global challenges of food and water security, climate change, and many other aspects of environmental sustainability. What are the key findings you collected in your paper? By taking an integrated, circular economy approach to cultivating marine microalgae, we can close the gap in human nutrition projected for 2050 and simultaneously reduce many of the negative impacts our current food production system has on climate and the global environment. What most surprised or interested you about your findings? We always knew that the high productivity of marine microalgae could help us reduce the carbon and land footprints of agriculture. However, what came as an unexpected surprise was just how much protein could potentially be produced from such a small footprint of non-arable, coastal land in the Global South. The implications of our results for sustainable development are profound. What are the next steps for research on this topic? As green venture capitalist John Doerr emphasizes in his recent book*, it’s all about speed and scale. Our window of time to solve these global challenges is narrow, and the solutions are on a scale that our policymakers have difficulty even imagining, let alone investing in. The future of algae-based solutions in achieving global food security and environmental sustainability will depend on the actions taken by the investment community and governments today. *Speed & Scale: An Action Plan for Solving Our Climate Crisis Now Reference: “Algal solutions: Transforming marine aquaculture from the bottom up for a sustainable future” by Charles H. Greene and Celina M. Scott-Buechler, 17 October 2022, PLOS Biology. DOI: 10.1371/journal.pbio.3001824
By examining RNA in hundreds of thousands of individual brain cells, Scripps Research scientists further support that alcohol use disorder could accelerate Alzheimer’s disease progression, paving the way for future targeted treatments. New research from Scripps Research links Alzheimer’s disease and alcohol use disorder, showing similar gene expression changes in the brain that impact inflammation and cell function. Using single-cell transcriptomics, the study indicates that alcohol use may exacerbate Alzheimer’s disease by affecting shared molecular pathways. Larger datasets are anticipated to provide further insights. Gene Expression Links Between Alzheimer’s and Alcohol Use Nearly 7 million Americans have Alzheimer’s disease, and this number is predicted to double by 2060. While aging and genetic predisposition are the most important risk factors for Alzheimer’s, epidemiological studies suggest that lifestyle factors including alcohol use could also impact disease onset and progression. Now, Scripps Research scientists have shown that Alzheimer’s and alcohol use disorder (AUD) are associated with similarly altered gene expression patterns in the brain, supporting the idea that alcohol use may promote Alzheimer’s disease progression. The study, published in eNeuro on September 19, 2024, could inform future preventative and treatment strategies. Shared Molecular Mechanisms in Alzheimer’s and Alcohol Use Disorder “We found several cell-type-specific genes and pathways that are dysregulated in both Alzheimer’s disease and alcohol, which supports the hypothesis that alcohol use disorder can accelerate Alzheimer’s disease progression by impinging on some of the same molecular mechanisms that are affected by Alzheimer’s,” says senior author Pietro Paolo Sanna, MD, a professor in the Immunology and Microbiology Department at Scripps Research. “By understanding these dysregulations with this level of molecular detail, we can understand what’s causing these diseases, and we can also identify targets that could be used therapeutically.” This is the first time researchers have used single cell transcriptomics—a method that analyzes gene expression within individual cells by sequencing their RNA—to compare changes associated with Alzheimer’s disease and AUD in different populations of human brain cells. The study builds upon previously published research in the Sanna lab that showed that excessive alcohol consumption accelerates Alzheimer’s progression in mice that are genetically predisposed to the disease. Researchers characterized the gene expression of more than 100,000 individual cells from brains of humans with Alzheimer’s disease and compared the patterns to those in individuals with alcohol use disorder (AUD). Compared to healthy individuals, they showed that there was significant overlap in gene expression changes for those with Alzheimer’s and AUD. Pathways that were downregulated in AUD and at least one AD stage are shown in purple, and pathways that are upregulated in AUD and at least one AD stage are shown in pink. Credit: Arpita Joshi and Pietro P. Sanna (Scripps Research) Study Methodology and Comparative Gene Analysis To examine cell-specific gene expression changes, the team analyzed RNA sequencing data from hundreds of thousands of individual brain cells from 75 patients with varying stages of Alzheimer’s disease (early, intermediate or advanced), and 10 patients without Alzheimer’s. Then, they compared this Alzheimer’s gene expression data with previously published RNA sequencing data from individuals with AUD. They showed that both AUD and Alzheimer’s are associated with similar gene expression changes in the brain, including upregulation of inflammatory genes and pathways, disruption to cell signaling and cell-death-related pathways, and changes to blood vessel cells. The Broader Implications of Alcohol Use as a Risk Factor “What we’ve presented here is a differential analysis of two disorders that cause cognitive decline,” says first author Arpita Joshi, PhD, a staff scientist in Sanna’s lab at Scripps Research. “It deepens our understanding of Alzheimer’s disease and what the three clinically defined stages of Alzheimer’s entail, and it underscores the importance of considering alcohol use disorder as a risk factor for Alzheimer’s.” Because the study was based on a small sample size for AUD, in the future, researchers plan to repeat their analysis using larger gene expression databases from individuals with AUD, which they expect to become available in the next year. The Global Effort to Understand Disease at the Cellular Level “We are eagerly awaiting the release of larger alcohol use datasets so that we can test the robustness of these findings and examine the commonalities between the two disorders with finer cell-type granularity,” says Joshi. “This is a global effort to unravel complex diseases at the single-cell level, which will lead to a better understanding of the molecular and cellular perturbations in individuals with Alzheimer’s disease, alcohol use disorder, and their interactions.” Reference: “Transcriptional Patterns in Stages of Alzheimer’s Disease Are Cell-Type–Specific and Partially Converge with the Effects of Alcohol Use Disorder in Humans” by Arpita Joshi, Federico Manuel Giorgi and Pietro Paolo Sanna, 19 September 2024, eNeuro. DOI: 10.1523/ENEURO.0118-24.2024 In addition to Sanna and Joshi, the study was co-authored by Federico Manuel Giorgi of Scripps Research and the University of Bologna. This work was supported by funding from the National Institutes of Health (AA021667, AA028982, DA046170, DA046204, and DA053801)
Researchers have identified over 11,000 circRNAs in brain cells linked to Parkinson’s and Alzheimer’s. These circRNAs may offer insights into the diseases’ molecular foundations and have potential applications as biomarkers and in RNA-based treatments. Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells. Investigators found and cataloged mysterious RNA circles that are linked to brain cell identity Findings show that circular RNA is produced by brain cells damaged in Parkinson’s and Alzheimer’s disease Circular RNA production from one Parkinson’s gene DNAJC6 was abnormal even prior to symptom onset Scientists are now delving deeper into neurological diseases by studying circular RNAs (circRNAs) in brain cells. A new study by investigators from the Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, identified over 11,000 distinct RNA circles that characterized brain cells implicated in Parkinson’s disease and Alzheimer’s disease. Their results will be published today (September 18) in the journal Nature Communications. “Circular RNA has long been cast aside as junk, but we believe it has an important role in programming human brain cells and synapses,” said corresponding author Clemens Scherzer, MD, of the Department of Neurology and the American Parkinson Disease Association Center for Advanced Parkinson Research at Brigham. “We found that these circular RNAs were produced in large quantities by brain cells, including those associated with Parkinson’s and Alzheimer’s.” Scherzer and colleagues laser-captured neurons from 190 frozen postmortem human brain samples, including some non-neuronal cells for comparison. Then, they used ultra-deep, total RNA sequencing to study the exact sequences of genetic code found in the circular RNAs within these two cell types. Credit: Clemens Scherzer, Brigham and Women’s Hospital Research Methods and Key Findings For their research, Scherzer and his team laser-captured neurons from 190 frozen postmortem human brain samples, including some non-neuronal cells for comparison. Then, they used ultra-deep, total RNA sequencing to study the exact sequences of genetic code found in the circular RNAs within these two cell types. They found that 61% of all synaptic circRNAs they characterized were associated with brain disorders. Notably, they found 4,834 cell-type specific circular RNAs in dopamine and pyramidal neurons, two highly functioning brain cells. Dopamine neurons control movement, mood, and motivation while pyramidal neurons play an important role in memory and language. “It was surprising that the circular RNAs rather than the linear RNAs produced from these gene locations defined neuron identity,” said the first author Xianjun Dong, PhD, an assistant professor in the Department of Neurology and the Genomics and Bioinformatics Hub at the Brigham. “circRNA diversity provides finely tuned, cell type-specific information that is not explained by the corresponding linear RNAs from the same gene.” Scherzer and colleagues laser-captured neurons from 190 frozen postmortem human brain samples, including some non-neuronal cells for comparison. Then, they used ultra-deep, total RNA sequencing to study the exact sequences of genetic code found in the circular RNAs within these two cell types. Credit: Clemens Scherzer, Brigham and Women’s Hospital Potential Implications and Future Prospects Degeneration of these dopamine and pyramidal neurons plays a key role in the development of neurological disorders. When researchers investigated this connection further, they found that a surprising number of Parkinson’s and Alzheimer’s genes produced circular RNA. For example, expression of one circRNA produced from the Parkinson’s gene DNAJC6 was reduced in vulnerable dopamine neurons even prior to symptom onset. “Naturally occurring circRNAs have the potential to serve as biomarkers for specific brain cells implicated in early, prodromal stages of a disease,” Scherzer said. “Circular RNAs cannot easily be broken down, making them a powerful tool as reporters and for delivering therapies. They could be rewritten synthetically and harnessed as future digital RNA medicines.” The researchers identified that genes associated with different diseases produced circRNAs in particular cell types. For example, addiction-associated genes gave rise to circRNAs in dopamine neurons, autism-associated genes in pyramidal neurons, and cancer associated genes in non-neuronal cells. Limitations of the current study include an incomplete understanding of how this complex RNA machinery specifies neuron and synapse identity. Future research can investigate how these circRNAs arise and function and survey additional genetic regulators that govern their behavior. Nevertheless, the current findings provide the most comprehensive analysis of circRNAs in human brain cells to date and suggest they can be leveraged for RNA diagnostics and medicines used to treat neurological conditions. “The discovery of circular RNAs changes our understanding of the molecular mechanisms behind neurodegenerative disorders,” Dong said. “Circular RNAs are much more durable than linear RNAs and hold promise as RNA therapies and RNA biomarkers.” Reference: “Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease” by Xianjun Dong, Yunfei Bai, Zhixiang Liao, David Gritsch, Xiaoli Liu, Tao Wang, Rebeca Borges-Monroy, Alyssa Ehrlich, Geidy E. Serrano, Mel B. Feany, Thomas G. Beach and Clemens R. Scherzer, 18 September 2023, Nature Communications. DOI: 10.1038/s41467-023-40348-0 Funding: This study was funded in part by the American Parkinson Disease Association, NIH, and the U.S. Department of Defense, with additional contributions from the ASAP Foundation. Disclosures: Scherzer has served as consultant, scientific collaborator or on scientific advisory boards for Sanofi, Berg Health, Pfizer, Biogen, and has received grants from National Institute of Health (NIH), U.S. Department of Defense, American Parkinson Disease Association (APDA), Aligning Science Across Parkinson’s (ASAP), and The Michael J. Fox Foundation. Dong has received funding from NIH, APDA, and ASAP.
DVDV1551RTWW78V
Custom graphene foam processing factory Taiwan 》designed for quality-conscious brands who care about user experienceOne-stop OEM/ODM solution provider China 》helping brands deliver comfort and performanceSoft-touch pillow OEM service in Thailand 》craftsmanship meets efficiency for maximum value